Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(25%)
Terminated
1(25%)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
1
25%
Ph phase_2
1
25%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting125%
terminated125%
unknown250%

Recent Activity

1 active trials
Showing 4 of 4
terminatedphase_4

Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study

NCT04594746
recruitingphase_2

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

NCT06067438
unknownnot_applicable

Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death

NCT01722942
unknownphase_3

A Trial Testing Amiodarone in Chagas Cardiomiopathy

NCT03193749

Clinical Trials (4)

Showing 4 of 4 trials
NCT04594746Phase 4

Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study

Terminated
NCT06067438Phase 2

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Recruiting
NCT01722942Not Applicable

Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death

Unknown
NCT03193749Phase 3

A Trial Testing Amiodarone in Chagas Cardiomiopathy

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4